Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis
File version
Author(s)
Bernatsky, S
Baron, M
Proudman, S
Stevens, W
Sahhar, J
Wang, M
Steele, RJ
Baron, M
Hudson, M
Gyger, G
Hoa, S
Pope, J
Larché, M
Nash, P
et al.
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Journal Title
Chest
Conference Title
Book Title
Edition
Volume
160
Issue
6
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Cardiovascular medicine and haematology
Persistent link to this record
Citation
Hoa, S; Bernatsky, S; Baron, M; Proudman, S; Stevens, W; Sahhar, J; Wang, M; Steele, RJ; Baron, M; Hudson, M; Gyger, G; Hoa, S; Pope, J; Larché, M; Khalidi, N; Masetto, A; Sutton, E; Rodriguez-Reyna, TS; Maltez, N; Thorne, C; Fortin, PR; Ikic, A; Robinson, D; Jones, N; LeClercq, S; Mathieu, JP; Docherty, P; Smith, D; Fritzler, M; Croyle, L; de Jager, J; Ferdowsi, N; Hill, C; Laurent, R; Lester, S; Major, G; Morrisroe, K; Nash, P; Ngian, G; Nikpour, M; Rischmueller, M; Roddy, J; Schrieber, L; Stevens, W; Strickland, G; Sturgess, A; Thakkar, V; Tymms, K; Walker, J; Youseff, P; Zochling, J; Nikpour, M; Hudson, M, Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis, Chest, 2021, 160 (6), pp. 2158-2162